The ideal peptide plant

28 May 2013

Expert views

Dr Olivier Ludemann-Hombourger of PolyPeptide Laboratories France looks at the latest process trends in peptide manufacturing and key drivers for innovation.[…]

Dr Olivier Ludemann-Hombourger of PolyPeptide Laboratories France looks at the latest process trends in peptide manufacturing and key drivers for innovation.

Olivier Ludemann-Hombourger, Speciality Chemicals Magazine May 2013

The ideal peptide plant

Related posts

Impurities in Peptide Drug Substance and Challenges Faced during Registration (in US, EU, Brazil and China Markets) and Commercial Phase

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand

PolyPeptide supports landmark publication on sustainable peptide synthesis